This study is testing two treatments for pulmonary embolism (PE), a condition where blood clots block the lungs' blood vessels. The study compares using only blood thinners (medicines that help prevent clots) with using blood thinners plus a special device called the EkoSonic™ Endovascular device, which helps dissolve the clots. Participants will be randomly assigned to one of these groups and monitored over 12 months with check-ups in the hospital and at specific time points like 7 days, 30 days, 6 months, and 12 months. The goal is to see which method is better at reducing serious risks like death from PE.
- Participation lasts for 12 months with several follow-up visits.
- Participants must be between 18-80 years old and meet certain health criteria.
- Risks may include side effects from treatments; discuss with your doctor.
How understandable was the trial content above?
Hard to understand
Easy to understand